Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.

Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc ...

Find insight on Hims & Hers Health, EssilorLuxottica, Bayer and more in the latest Market Talks covering Health Care.

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...